Literature DB >> 23209224

Genome sequence of Moraxella catarrhalis RH4, an isolate of seroresistant lineage.

Aldert Zomer1, Stefan P W de Vries, Kristian Riesbeck, Andreas L Meinke, Peter W M Hermans, Hester J Bootsma.   

Abstract

Here we report the annotated genome sequence of Moraxella catarrhalis strain RH4, a seroresistant-lineage strain isolated from the blood of an infected patient. This genome sequence will allow us to gain further insight into the genetic diversity of clinical M. catarrhalis isolates and will facilitate study of M. catarrhalis pathogenesis.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23209224      PMCID： PMC3510597          DOI： 10.1128/JB.01833-12

Source DB:  PubMed          Journal:  J Bacteriol        ISSN： 0021-9193            Impact factor:   3.490


  11 in total

1.  Genome analysis of Moraxella catarrhalis strain BBH18, [corrected] a human respiratory tract pathogen.

Authors:  Stefan P W de Vries; Sacha A F T van Hijum; Wolfgang Schueler; Kristian Riesbeck; John P Hays; Peter W M Hermans; Hester J Bootsma
Journal:  J Bacteriol       Date:  2010-05-07       Impact factor: 3.490

2.  Ray: simultaneous assembly of reads from a mix of high-throughput sequencing technologies.

Authors:  Sébastien Boisvert; François Laviolette; Jacques Corbeil
Journal:  J Comput Biol       Date:  2010-10-20       Impact factor: 1.479

3.  Bacterial secreted proteins are required for the internaliztion of Campylobacter jejuni into cultured mammalian cells.

Authors:  M E Konkel; B J Kim; V Rivera-Amill; S G Garvis
Journal:  Mol Microbiol       Date:  1999-05       Impact factor: 3.501

4.  Comparative analysis and supragenome modeling of twelve Moraxella catarrhalis clinical isolates.

Authors:  Jeremiah J Davie; Josh Earl; Stefan P W de Vries; Azad Ahmed; Fen Z Hu; Hester J Bootsma; Kim Stol; Peter W M Hermans; Robert M Wadowsky; Garth D Ehrlich; John P Hays; Anthony A Campagnari
Journal:  BMC Genomics       Date:  2011-01-26       Impact factor: 3.969

5.  The Moraxella catarrhalis immunoglobulin D-binding protein MID has conserved sequences and is regulated by a mechanism corresponding to phase variation.

Authors:  Andrea Möllenkvist; Therése Nordström; Christer Halldén; Jens Jørgen Christensen; Arne Forsgren; Kristian Riesbeck
Journal:  J Bacteriol       Date:  2003-04       Impact factor: 3.490

6.  Genotypic and phenotypic relatedness of 80 strains of Branhamella catarrhalis of worldwide origin.

Authors:  J J Christensen; J Ursing; B Bruun
Journal:  FEMS Microbiol Lett       Date:  1994-06-01       Impact factor: 2.742

7.  Metabolic analysis of Moraxella catarrhalis and the effect of selected in vitro growth conditions on global gene expression.

Authors:  Wei Wang; Larry Reitzer; David A Rasko; Melanie M Pearson; Robert J Blick; Cassie Laurence; Eric J Hansen
Journal:  Infect Immun       Date:  2007-07-09       Impact factor: 3.441

8.  Toward almost closed genomes with GapFiller.

Authors:  Marten Boetzer; Walter Pirovano
Journal:  Genome Biol       Date:  2012-06-25       Impact factor: 13.583

9.  Projector 2: contig mapping for efficient gap-closure of prokaryotic genome sequence assemblies.

Authors:  Sacha A F T van Hijum; Aldert L Zomer; Oscar P Kuipers; Jan Kok
Journal:  Nucleic Acids Res       Date:  2005-07-01       Impact factor: 16.971

10.  The RAST Server: rapid annotations using subsystems technology.

Authors:  Ramy K Aziz; Daniela Bartels; Aaron A Best; Matthew DeJongh; Terrence Disz; Robert A Edwards; Kevin Formsma; Svetlana Gerdes; Elizabeth M Glass; Michael Kubal; Folker Meyer; Gary J Olsen; Robert Olson; Andrei L Osterman; Ross A Overbeek; Leslie K McNeil; Daniel Paarmann; Tobias Paczian; Bruce Parrello; Gordon D Pusch; Claudia Reich; Rick Stevens; Olga Vassieva; Veronika Vonstein; Andreas Wilke; Olga Zagnitko
Journal:  BMC Genomics       Date:  2008-02-08       Impact factor: 3.969
View more
  6 in total

1.  A Moraxella catarrhalis two-component signal transduction system necessary for growth in liquid media affects production of two lysozyme inhibitors.

Authors:  Stephanie N Joslin; Christine Pybus; Maria Labandeira-Rey; Amanda S Evans; Ahmed S Attia; Chad A Brautigam; Eric J Hansen
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

Review 2.  Panel 4: Report of the Microbiology Panel.

Authors:  Stephen J Barenkamp; Tasnee Chonmaitree; Anders P Hakansson; Terho Heikkinen; Samantha King; Johanna Nokso-Koivisto; Laura A Novotny; Janak A Patel; Melinda Pettigrew; W Edward Swords
Journal:  Otolaryngol Head Neck Surg       Date:  2017-04       Impact factor: 3.497

3.  Comparative Genomic Analyses of the Moraxella catarrhalis Serosensitive and Seroresistant Lineages Demonstrate Their Independent Evolution.

Authors:  Joshua P Earl; Stefan P W de Vries; Azad Ahmed; Evan Powell; Matthew P Schultz; Peter W M Hermans; Darryl J Hill; Zhemin Zhou; Crystala I Constantinidou; Fen Z Hu; Hester J Bootsma; Garth D Ehrlich
Journal:  Genome Biol Evol       Date:  2016-04-06       Impact factor: 3.416

4.  ATP-Binding Cassette (ABC) Transporters of the Human Respiratory Tract Pathogen, Moraxella catarrhalis: Role in Virulence.

Authors:  Timothy F Murphy; Aimee L Brauer; Antoinette Johnson; Charmaine Kirkham
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

Review 5.  Interactions of Bacteriophages and Bacteria at the Airway Mucosa: New Insights Into the Pathophysiology of Asthma.

Authors:  Panagiota Tzani-Tzanopoulou; Dimitrios Skliros; Spyridon Megremis; Paraskevi Xepapadaki; Evangelos Andreakos; Nina Chanishvili; Emmanouil Flemetakis; Grigoris Kaltsas; Styliani Taka; Evangelia Lebessi; Anastassios Doudoulakakis; Nikolaos G Papadopoulos
Journal:  Front Allergy       Date:  2021-01-26

6.  Conserved Patterns of Microbial Immune Escape: Pathogenic Microbes of Diverse Origin Target the Human Terminal Complement Inhibitor Vitronectin via a Single Common Motif.

Authors:  Teresia Hallström; Birendra Singh; Peter Kraiczy; Sven Hammerschmidt; Christine Skerka; Peter F Zipfel; Kristian Riesbeck
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.